WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H596439
CAS#: 7349-37-3
Description: d-Inpea HCl is a bioactive chemical.
Hodoodo Cat#: H596439
Name: d-Inpea HCl
CAS#: 7349-37-3
Chemical Formula: C11H17ClN2O3
Exact Mass: 0.00
Molecular Weight: 260.710
Elemental Analysis: C, 50.68; H, 6.57; Cl, 13.60; N, 10.74; O, 18.41
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: d-Inpea HCl; d-Inpea hydrochloride; L-(+)-Inpea hydrochloride; (+)-Inpea hydrochloride;
IUPAC/Chemical Name: (S)-2-(isopropylamino)-1-(4-nitrophenyl)ethan-1-ol hydrochloride
InChi Key: STGOXRVTUNXXLQ-RFVHGSKJSA-N
InChi Code: InChI=1S/C11H16N2O3.ClH/c1-8(2)12-7-11(14)9-3-5-10(6-4-9)13(15)16;/h3-6,8,11-12,14H,7H2,1-2H3;1H/t11-;/m1./s1
SMILES Code: O[C@H](CNC(C)C)C1=CC=C([N+]([O-])=O)C=C1.[H]Cl
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 260.71 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1: Gaion RM, Trento M. The role of adrenergic, purinergic and opiate receptors in the control of prostacyclin-induced contraction in the guinea-pig ileum. Arch Int Pharmacodyn Ther. 1984 Sep;271(1):33-44. PubMed PMID: 6093721.
2: Nishimura T, Kita S, Abiko Y. Effects of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA) and propranolol and their dextro-isomers on hemodynamic and metabolic responses to isoproterenol in dogs. J Pharmacol Exp Ther. 1983 Aug;226(2):595-602. PubMed PMID: 6688273.
3: Caparrotta L, Prosdocimi M, Gaion RM. Effect of diamide on isolated guinea pig atria. Pharmacol Res Commun. 1983 Jun;15(6):603-11. PubMed PMID: 6193539.
4: Rossi F, Cuparencu B, DiMezza F, Lampa E, Giordano L, Quartuccio A, Marmo E. Intracarotidal injection of beta-adrenergic blocking agents: variations in the carotid sinus baro- and chemoreceptor activity. Res Commun Chem Pathol Pharmacol. 1980 Nov;30(2):211-20. PubMed PMID: 6108598.
5: Singh RC, Srivastava VK, Tayal G, Srivastava RK, Prasad DN. Enhancement of insulin hypoglycaemia by beta adrenoceptor antagonists. Indian J Physiol Pharmacol. 1978 Jan-Mar;22(1):61-5. PubMed PMID: 28289.
6: Marmo E, Rossi F, Lampa E, Pedone P, Rosatti F, Del Vecchio F. [Experimental analysis of interactions between a beta-adrenolytic agent D(-)inpea and a minor tranquilizer diazepam]. Clin Ter. 1977 Sep 15;82(5):425-73. Italian. PubMed PMID: 579168.
7: Barar FS, Madan BR. Tremorine-oxotremorine-induced tremor, hypothermia and analgesia, and physostigmine toxicity, in mice after pretreatment with beta-adrenoceptor antagonists. J Pharm Pharmacol. 1976 Apr;28(4):286-9. PubMed PMID: 6716.
8: Brus R. Activity of some enzymes which synthesize and metabolize catecholamines in the brain and peripheral organs in developing rats. Arch Immunol Ther Exp (Warsz). 1975;23(4):449-57. PubMed PMID: 169762.
9: Rao VS, Sharma PL. Potentiating effect of d-INPEA on prostaglandin (PGF 2 and PGE 2 )-evoked contractions of the isolated rat uterus. Eur J Pharmacol. 1972 Dec;20(3):363-5. PubMed PMID: 4643458.
10: Arrigo L, Macrì I, Rigon-Macrì P. [Effect of an adrenergic beta receptor blockader (D(-)INPEA) on various functional parameters of the rabbit heart]. Boll Soc Ital Biol Sper. 1971 Oct 30;47(20):647-50. Italian. PubMed PMID: 4401207.
11: Saini RK, Sharma PL. Application of potentiating effect of d-INPEA on oxytocin-evoked responses in the isolated rat uterus to bioassay of oxytocin. Eur J Pharmacol. 1971 May;14(4):402-5. PubMed PMID: 5157768.
12: Boakes RJ, Bradley PB, Brookes N, Candy JM, Wolstencroft JH. Actions of noradrenaline, other sympathomimetic amines and antagonists on neurones in the brain stem of the cat. Br J Pharmacol. 1971 Mar;41(3):462-79. PubMed PMID: 5576254; PubMed Central PMCID: PMC1702877.
13: Abiko Y, Minamidate A, Ito M. Comparison of the effects of pronethalol, MJ 1999, D(-) INPEA and L(+) INPEA on the pressor response to acethycholine in atropinized dogs. Arch Int Pharmacodyn Ther. 1969 May;179(1):130-6. PubMed PMID: 4390661.
14: Phillis JW, Tebĕcis AK. The responses of thalamic neurons to iontophoretically applied monoamines. J Physiol. 1967 Oct;192(3):715-45. PubMed PMID: 4293789; PubMed Central PMCID: PMC1365538.
15: Murmann W, Almirante L, Saccani-Guelfi M. Effects of hexobarbitone, ether, morphine, and urethane upon the acute toxicity of propranolol and D-(--)-INPEA. J Pharm Pharmacol. 1966 Oct;18(10):692-4. PubMed PMID: 4382081.
